Item Type | Name |
Academic Article
|
Association of the tissue kallikrein gene promoter with ESRD and hypertension.
|
Academic Article
|
Surgical management of atherosclerotic renovascular disease.
|
Academic Article
|
Prevalence of nephropathy in black patients with type 2 diabetes mellitus.
|
Academic Article
|
Linkage heterogeneity of end-stage renal disease on human chromosome 10.
|
Academic Article
|
Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy.
|
Academic Article
|
Impact of birth weight on familial aggregation of end-stage renal disease.
|
Academic Article
|
Association of an IL-1A 3'UTR polymorphism with end-stage renal disease and IL-1 alpha expression.
|
Academic Article
|
Susceptibility genes for hypertension and renal failure.
|
Academic Article
|
The importance of family history on the development of renal disease.
|
Academic Article
|
Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus.
|
Academic Article
|
Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease.
|
Academic Article
|
The relationship between albuminuria and hormone therapy in postmenopausal women.
|
Academic Article
|
P-selectin gene haplotype associations with albuminuria in the Diabetes Heart Study.
|
Academic Article
|
Recent progress in inherited kidney diseases.
|
Academic Article
|
Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus.
|
Academic Article
|
Obesity is associated with family history of ESRD in incident dialysis patients.
|
Academic Article
|
A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.
|
Academic Article
|
An update on pruritus associated with CKD.
|
Academic Article
|
Skin barrier structure and function and their relationship to pruritus in end-stage renal disease.
|
Academic Article
|
Genetic factors in diabetic nephropathy.
|
Academic Article
|
Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
|
Academic Article
|
Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population.
|
Academic Article
|
Association analysis of the ephrin-B2 gene in African-Americans with end-stage renal disease.
|
Academic Article
|
Evaluation of genetic association and expression reduction of TRPC1 in the development of diabetic nephropathy.
|
Academic Article
|
A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients.
|
Academic Article
|
Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease.
|
Academic Article
|
Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities.
|
Academic Article
|
The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans.
|
Academic Article
|
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
|
Academic Article
|
Effect of community characteristics on familial clustering of end-stage renal disease.
|
Academic Article
|
Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.
|
Academic Article
|
Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.
|
Academic Article
|
Reappraisal of the impact of race on survival in patients on dialysis.
|
Academic Article
|
Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy.
|
Academic Article
|
A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes.
|
Academic Article
|
The spectrum of MYH9-associated nephropathy.
|
Academic Article
|
Sickle cell trait and development of microvascular complications in diabetes mellitus.
|
Academic Article
|
Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease.
|
Academic Article
|
Genetics and the kidney: promise, potential, and challenges. Introduction.
|
Academic Article
|
Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.
|
Academic Article
|
Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes.
|
Academic Article
|
Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans.
|
Academic Article
|
Protein kinase C-ß gene variants and type 2 diabetes-associated kidney failure: What can we learn from gene association studies in diabetic nephropathy?
|
Academic Article
|
Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes.
|
Academic Article
|
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
|
Academic Article
|
Meta-analysis of genome-wide linkage scans for renal function traits.
|
Academic Article
|
Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis.
|
Academic Article
|
Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
|
Academic Article
|
Target organ damage in African American hypertension: role of APOL1.
|
Academic Article
|
Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
|
Academic Article
|
The new era of APOL1-associated glomerulosclerosis.
|
Academic Article
|
A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: time to dispense with the hemoglobin A1C in end-stage kidney disease.
|
Academic Article
|
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
|
Academic Article
|
Relevance of the ACTN4 gene in African-Americans with non-diabetic end-stage renal disease.
|
Academic Article
|
Preeclampsia and risk for subsequent ESRD in populations of European ancestry.
|
Academic Article
|
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.
|
Academic Article
|
End-stage renal failure in African Americans: insights in kidney disease susceptibility.
|
Academic Article
|
Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients.
|
Academic Article
|
Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster.
|
Academic Article
|
Renal artery calcified plaque associations with subclinical renal and cardiovascular disease.
|
Academic Article
|
A genome scan for diabetic nephropathy in African Americans.
|
Academic Article
|
A genome scan for ESRD in black families enriched for nondiabetic nephropathy.
|
Academic Article
|
A genome scan for all-cause end-stage renal disease in African Americans.
|
Academic Article
|
A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004.
|
Academic Article
|
Genetic factors in end-stage renal disease.
|
Academic Article
|
Relationship between albuminuria and cardiovascular disease in Type 2 diabetes.
|
Academic Article
|
Association of the mu-opioid receptor gene with type 2 diabetes mellitus in an African American population.
|
Academic Article
|
Population-based screening for family history of end-stage renal disease among incident dialysis patients.
|
Academic Article
|
Genetic determinants of albuminuria and renal disease in diabetes mellitus.
|
Academic Article
|
Genetics of progressive renal failure in diabetic kidney disease.
|
Academic Article
|
Genetic factors in common complex renal and cardiovascular diseases.
|
Academic Article
|
Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations.
|
Academic Article
|
Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).
|
Academic Article
|
The prevalence of resistant bacterial colonization in chronic hemodialysis patients.
|
Academic Article
|
Familial clustering of chronic kidney disease.
|
Academic Article
|
Chronic kidney disease: cause and consequence of cardiovascular disease.
|
Academic Article
|
Non-surgical salvage of thrombosed arterio-venous fistulae: a case series and review of the literature.
|
Academic Article
|
Kidney volume associations with subclinical renal and cardiovascular disease: the Diabetes Heart Study.
|
Academic Article
|
Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy.
|
Academic Article
|
Chromogranin A polymorphisms are associated with hypertensive renal disease.
|
Academic Article
|
Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies.
|
Academic Article
|
Association of arachidonate 12-lipoxygenase genotype variation and glycemic control with albuminuria in type 2 diabetes.
|
Academic Article
|
Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease.
|
Academic Article
|
MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
|
Academic Article
|
Hypertension-associated kidney disease: perhaps no more.
|
Academic Article
|
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
|
Academic Article
|
Treating anemia with erythropoiesis-stimulating agents: effects on quality of life.
|
Academic Article
|
Susceptibility genes in common complex kidney disease.
|
Academic Article
|
Essential hypertension and risk of nephropathy: a reappraisal.
|
Academic Article
|
Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis.
|
Academic Article
|
Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
|
Academic Article
|
Association of polymorphisms in the klotho gene with severity of non-diabetic ESRD in African Americans.
|
Academic Article
|
Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA.
|
Academic Article
|
Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
|
Academic Article
|
The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
|
Academic Article
|
A genome-wide association study for diabetic nephropathy genes in African Americans.
|
Academic Article
|
Intensive blood-pressure control in hypertensive chronic kidney disease.
|
Academic Article
|
Effects of race on albuminuria and risk of cardiovascular and kidney disease.
|
Academic Article
|
Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
|
Academic Article
|
Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
|
Academic Article
|
Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
|
Academic Article
|
Risk factors: Race, renal disease and albuminuria.
|
Academic Article
|
Novel findings and future directions on the genetics of hypertension.
|
Academic Article
|
Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
|
Academic Article
|
Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function.
|
Academic Article
|
Assessing glycemic control in diabetic patients with severe nephropathy.
|
Academic Article
|
Glycemic control in patients with diabetes and nephropathy.
|
Concept
|
Kidney
|
Concept
|
Kidney Tubules, Proximal
|
Concept
|
Kidney Tubules
|
Concept
|
Kidney Tubules, Distal
|
Concept
|
Kidney Function Tests
|
Concept
|
Kidney Glomerulus
|
Concept
|
Kidney Transplantation
|
Concept
|
Kidney Diseases
|
Concept
|
Kidney Failure, Chronic
|
Concept
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
|
Academic Article
|
Genome-wide association and functional follow-up reveals new loci for kidney function.
|
Academic Article
|
Immune complex disease with a lupus-like pattern of deposition in an antinuclear antibody-negative patient.
|
Academic Article
|
Ethnicity, medical insurance, and living kidney donation.
|
Academic Article
|
Genotypic variation and outcomes in kidney transplantation: donor and recipient effects.
|
Academic Article
|
APOL1 and nephropathy progression in populations of African ancestry.
|
Academic Article
|
ABIN1 dysfunction as a genetic basis for lupus nephritis.
|
Academic Article
|
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
|
Academic Article
|
Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures.
|
Academic Article
|
APOL1 risk variants, race, and progression of chronic kidney disease.
|
Academic Article
|
Common variants in Mendelian kidney disease genes and their association with renal function.
|
Academic Article
|
Perceptions regarding genetic testing in populations at risk for nephropathy.
|
Academic Article
|
APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.
|
Academic Article
|
The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects.
|
Academic Article
|
Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis.
|
Academic Article
|
Relationships between electrochemical skin conductance and kidney disease in Type 2 diabetes.
|
Academic Article
|
Gene-gene interactions in APOL1-associated nephropathy.
|
Academic Article
|
Genetics in kidney disease in 2013: Susceptibility genes for renal and urological disorders.
|
Academic Article
|
Generalizability of genetic findings related to kidney function and albuminuria.
|
Academic Article
|
A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND).
|
Academic Article
|
Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
|
Academic Article
|
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
|
Academic Article
|
Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
|
Academic Article
|
Complement factor H gene associations with end-stage kidney disease in African Americans.
|
Academic Article
|
Risk of catheter-related bloodstream infection in elderly patients on hemodialysis.
|
Academic Article
|
The authors reply:.
|
Academic Article
|
Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
|
Academic Article
|
The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.
|
Academic Article
|
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
|
Academic Article
|
Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
|
Academic Article
|
The kidney research national dialogue: gearing up to move forward.
|
Academic Article
|
Risk factors: familial aggregation of ESRD in Europeans-is it in the genes?
|
Academic Article
|
Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity.
|
Academic Article
|
A comparison of type 2 diabetes risk allele load between African Americans and European Americans.
|
Academic Article
|
Kidney disease and cognitive function: African American-diabetes heart study MIND.
|
Academic Article
|
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.
|
Academic Article
|
Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND.
|
Academic Article
|
Should kidney donors be genotyped for APOL1 risk alleles?
|
Academic Article
|
Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.
|
Academic Article
|
Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor.
|
Academic Article
|
APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans.
|
Academic Article
|
APOL1 and kidney disease: new insights leading to novel therapies.
|
Academic Article
|
Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.
|
Academic Article
|
Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).
|
Academic Article
|
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
|
Academic Article
|
Electrochemical Skin Conductance in Diabetic Kidney Disease.
|
Academic Article
|
Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
|
Academic Article
|
A suPAR Biomarker for Chronic Kidney Disease.
|
Academic Article
|
Association Analysis of the Reticulon 1 Gene in End-Stage Kidney Disease.
|
Academic Article
|
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
|
Academic Article
|
Characterization of circulating APOL1 protein complexes in African Americans.
|
Academic Article
|
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.
|
Academic Article
|
Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus.
|
Academic Article
|
APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
|
Academic Article
|
Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.
|
Academic Article
|
APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
|
Academic Article
|
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.
|
Academic Article
|
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.
|
Academic Article
|
Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.
|
Academic Article
|
APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction.
|
Academic Article
|
APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.
|
Academic Article
|
APOL1 genotype, blood pressure, and survival in African Americans with nondiabetic nephropathy.
|
Grant
|
Genetic Determinants of Renal Transplant Survival from African American Donors
|
Grant
|
Natural History of MYH9-Associated Nephropathy
|
Grant
|
Continuation of the FIND Study
|
Grant
|
An Integrative Genomic Approach to APOL1-Associated Nephropathy.
|
Academic Article
|
Genetic epidemiology in kidney disease.
|
Academic Article
|
A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.
|
Academic Article
|
A tripartite complex of suPAR, APOL1 risk variants and avß3 integrin on podocytes mediates chronic kidney disease.
|
Academic Article
|
Effects of Intensive BP Control in CKD.
|
Academic Article
|
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
|
Academic Article
|
Vascular Access Placement Order and Outcomes in Hemodialysis Patients: A Longitudinal Study.
|
Grant
|
Wake Forest APOLLO Scientific and Data Research Center
|
Academic Article
|
Need to Reclassify Etiologies of ESRD on the CMS 2728 Medical Evidence Report.
|
Academic Article
|
Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
|
Academic Article
|
Apolipoprotein L1 Gene Effects on Kidney Transplantation.
|
Academic Article
|
FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes.
|
Academic Article
|
APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial.
|
Academic Article
|
An Exome-wide Association Study for Type 2 Diabetes-Attributed End-Stage Kidney Disease in African Americans.
|
Academic Article
|
JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans.
|
Academic Article
|
Evaluation of Potential Living Kidney Donors in the APOL1 Era.
|
Academic Article
|
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
|
Academic Article
|
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
|
Academic Article
|
The APOL1 Long-Term Kidney Transplantation Outcomes Network-APOLLO.
|
Academic Article
|
Molecular Pathways Underlying Adaptive Repair of the Injured Kidney: Novel Donation After Cardiac Death and Acute Kidney Injury Platforms.
|
Academic Article
|
Glycated albumin and blood sugar control in advanced chronic kidney disease.
|
Academic Article
|
A catalog of genetic loci associated with kidney function from analyses of a million individuals.
|
Academic Article
|
Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.
|
Academic Article
|
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study design.
|
Academic Article
|
APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.
|
Academic Article
|
Protective association between JC polyoma viruria and kidney disease.
|
Academic Article
|
APOL1 and Mortality in Patients on Dialysis.
|
Academic Article
|
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
|
Academic Article
|
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.
|
Academic Article
|
The Impact of APOL1 on Chronic Kidney Disease and Hypertension.
|
Academic Article
|
Nephropathy Progression in African Americans With a Family History of ESKD: Implications for Clinical Trials in APOL1-Associated Nephropathy.
|
Academic Article
|
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
|
Academic Article
|
Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
|
Academic Article
|
JC Viruria Is Associated With Reduced Risk of Diabetic Kidney Disease.
|
Academic Article
|
Mechanisms of Injury in APOL1-associated Kidney Disease.
|
Academic Article
|
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
|
Academic Article
|
APOL1 Kidney-Risk Variants Induce Mitochondrial Fission.
|
Academic Article
|
A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: results of a feasibility study.
|
Academic Article
|
The Contribution of Kidney Disease to Cognitive Impairment in Patients with Type 2 Diabetes.
|
Academic Article
|
The impact of chronic kidney disease on cerebral hemodynamics: A transcranial Doppler study.
|
Academic Article
|
Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.
|
Academic Article
|
Genome-wide association study for time to failure of kidney transplants from African American deceased donors.
|
Academic Article
|
Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
|
Academic Article
|
Mechanisms of Stroke in Patients with Chronic Kidney Disease.
|
Academic Article
|
Biologic Underpinnings of Type 1 Diabetic Kidney Disease.
|
Academic Article
|
APOL1 Nephropathy Risk Variant Associations with Diseases beyond the Kidney: APOL1 and Sepsis.
|
Academic Article
|
Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.
|
Academic Article
|
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale.
|
Academic Article
|
APOL1 at 10 years: progress and next steps.
|
Academic Article
|
Primary care referrals to nephrology in patients with advanced kidney disease.
|
Academic Article
|
Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants.
|